July 9, 2009
Baillie and McCune accept professional pharmacy honors
Thomas A. Baillie, dean of the UW School of Pharmacy, has received an award from the International Isotope Society (IIS) for distinguished service to the Society. This prominent lifetime achievement award is given out every three years.
The IIS is a chartered, international organization that aims to promote the uses of isotopes and isotopically labeled compounds for studies to further improve the quality of life worldwide. Baillie has twice been a trustee for the IIS, and he served as its president in 1991.
Baillie has been the dean of the School of Pharmacy since this past October. He was a professor of medicinal chemistry in the school from 1981 to 1994 and then went on to spend 15 years at Merck & Co. Inc. While at Merck, he held multiple leadership positions, most recently as vice president and global head of drug metabolism and pharmacokinetics. His research in the subject areas of drug metabolism and pharmacokinetics is world-renowned.
Baillie has served on a number of advisory and scientific review panels at both the National Institutes of Health and the U.S. Food and Drug Administration. Among his degrees, he holds Ph.D. and D.Sc. degrees in chemistry from the University of Glasgow and an M.Sc. in biochemistry from the University of London.
***
Jeannine McCune, associate professor of pharmacy the UW School of Pharmacy, has accepted an invitation from the National Institutes of Health (NIH) Department of Health and Human Services (DHHS) to serve as a member of its Developmental Therapeutics Study Section, Center for Scientific Review.
According to DHHS, members are selected to fulfill this four-year role on the basis of their demonstrated competence and achievement in their scientific discipline as evidenced by the quality of research accomplishments, publications in scientific journals and other scientific activities, and honors. Membership on an NIH study section provides a unique opportunity to contribute to the national biomedical research effort.
McCune also serves as an associate member of the Clinical Research Division at Fred Hutchinson Cancer Research Center. Her research focuses on personalized dosing of medications in cancer patients, pharmacokinetics and population pharmacokinetics, and medication efficacy and safety. She currently has an NIH research grant from the National Heart, Lung and Blood Institute to identify pharmacologic biomarkers in patients receiving nonmyeloablative hematopoietic cell transplantation.
Among her professional distinctions, she is a member of the Institute for Public Health Genetics at UW, the American Society for Clinical Pharmacology and Therapeutics and the American College of Clinical Pharmacists.
